NYSE:APHA - Aphria Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $9.01
  • Forecasted Upside: 100.63 %
  • Number of Analysts: 8
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 8 Buy Ratings
  • 0 Strong Buy Ratings
$4.49
▲ +0.07 (1.58%)
1 month | 3 months | 12 months
Get New Aphria Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for APHA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for APHA

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$9.01
▲ +100.63% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Aphria in the last 3 months. The average price target is $9.01, with a high forecast of $11.75 and a low forecast of $7.00. The average price target represents a 100.63% upside from the last price of $4.49.
Buy
The current consensus among 8 contributing investment analysts is to buy stock in Aphria.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/8/2019
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/6/2019
  • 0 strong buy ratings
  • 8 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/4/2019
  • 0 strong buy ratings
  • 9 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/2/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/2/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/31/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/29/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/29/2020

Latest Recommendations

  • 0 strong buy ratings
  • 8 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/16/2020CIBCBoost Price TargetOutperform$7.50 ➝ $8.00Low
i
Rating by John Zamparo at CIBC
10/16/2020Cantor FitzgeraldLower Price TargetOverweight$15.50 ➝ $11.75High
i
10/5/2020Cantor FitzgeraldBoost Price TargetOverweight$12.50 ➝ $15.50High
i
8/17/2020CIBCUpgradeNeutral ➝ Outperform$7.50Low
i
7/30/2020Pi FinancialReiterated RatingBuyLow
i
Rating by J. Zandberg at Pi Financial
7/30/2020CIBCBoost Price TargetNeutral$6.00 ➝ $7.50Medium
i
7/27/2020Cantor FitzgeraldBoost Price TargetOverweight$10.50 ➝ $11.00High
i
7/15/2020Alliance Global PartnersReiterated RatingBuy$9.00Medium
i
Rating by Aaron Grey at Alliance Global Partners
7/13/2020Stifel NicolausUpgradeHold ➝ Buy$5.30 ➝ $8.00High
i
Rating by W. Andrew Carter at Stifel Nicolaus
5/8/2020Cantor FitzgeraldBoost Price TargetOverweight$9.50 ➝ $9.85Low
i
Rating by P. Zuanic at Cantor Fitzgerald
4/16/2020Eight CapitalUpgradeBuyMedium
i
Rating by Graeme Kreindler at Eight Capital
4/16/2020Stifel NicolausBoost Price TargetHold$4.50 ➝ $5.30Medium
i
Rating by W. Andrew Carter at Stifel Nicolaus
4/16/2020Bank of AmericaBoost Price TargetBuy$5.00 ➝ $7.00Medium
i
4/16/2020CIBCBoost Price TargetNeutral$6.00 ➝ $7.00High
i
Rating by John Zamparo at CIBC
4/15/2020Alliance Global PartnersReiterated RatingBuy$11.00 ➝ $9.00High
i
Rating by Aaron Grey at Alliance Global Partners
4/15/2020Cantor FitzgeraldLower Price TargetOverweight$9.30 ➝ $9.00Medium
i
Rating by P. Zuanic at Cantor Fitzgerald
4/1/2020Cantor FitzgeraldLower Price TargetOverweight$11.50 ➝ $9.30High
i
Rating by P. Zuanic at Cantor Fitzgerald
3/19/2020Bank of AmericaUpgradeNeutral ➝ BuyHigh
i
3/9/2020Stifel NicolausInitiated CoverageHold$4.50Medium
i
1/21/2020Alliance Global PartnersInitiated CoverageBuy$11.00Medium
i
1/20/2020Jefferies Financial GroupReiterated RatingBuy$10.30Medium
i
Rating by Owen Bennett at Jefferies Financial Group Inc.
1/14/2020CIBCUpgradeUnderperform ➝ Neutral$7.00High
i
Rating by John Zamparo at CIBC
1/13/2020Bank of AmericaInitiated CoverageNeutralHigh
i
11/5/2019Cantor FitzgeraldInitiated CoverageOverweight$10.40Medium
i
Rating by P. Zuanic at Cantor Fitzgerald
10/16/2019CIBCReiterated RatingSell$6.50High
i
10/15/2019Jefferies Financial GroupSet Price TargetBuy$8.30Low
i
Rating by Owen Bennett at Jefferies Financial Group Inc.
10/15/2019Pi FinancialSet Price TargetBuy$9.00Low
i
Rating by Jason Zandberg at Pi Financial
7/26/2019CIBCDowngradeNeutral ➝ Sector UnderperformHigh
i
5/24/2019Jefferies Financial GroupInitiated CoverageBuy ➝ Buy$11.00High
i
4/16/2019Clarus SecuritiesInitiated CoverageBuy$22.75High
i
2/21/2019Seaport Global SecuritiesInitiated CoverageBuy ➝ Buy$18.00Low
i
Rating by B. Hundley at Seaport Global Securities
2/2/2019CormarkSet Price TargetBuy$15.00High
i
Rating by Jesse Pytlak at Cormark
1/18/2019CIBCInitiated CoverageNeutral ➝ NeutralLow
i
12/13/2018Eight CapitalDowngradeHold$7.00Medium
i
Rating by Graeme Kreindler at Eight Capital
12/5/2018Canaccord GenuityReiterated RatingBuyHigh
i
(Data available from 10/29/2015 forward)
Aphria logo
Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.
Read More

Today's Range

Now: $4.49
$4.37
$4.51

50 Day Range

MA: $4.75
$4.22
$6.37

52 Week Range

Now: $4.49
$1.95
$6.44

Volume

4,171,085 shs

Average Volume

6,300,497 shs

Market Capitalization

$1.30 billion

P/E Ratio

49.89

Dividend Yield

N/A

Beta

2.19